col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


135 Results       Page 1

 [1] 
Elsevier: Clinical Lymphoma Myeloma & Leukemia
  original article Date Title Authors   All Authors
1 [GO] 2024―Sep―24 P-046 Identifying immune checkpoints on dysregulated T-cells as prognostic biomarkers for multiple myeloma patients with COVID-19 Ziping Li, Huiwen He, Fujing Zhang, Xianghong Jin, Yuhang Song, Shuangjiao Liu, et al. (+2)
2 [GO] 2024―Sep―24 P-089 Impact of COVID-19 on Outcomes With Teclistamab in the Phase 1/2 MajesTEC-1 Study in Patients With Relapsed/Refractory Multiple Myeloma Saad Usmani, Nizar J. Bahlis, Luciano Costa, María-Victoria Mateos Manteca, Ajay Nooka, Aurore Perrot, et al. (+6)
3 [GO] 2024―Aug―26 MM-289 Exosomal Vesicles as a Promising Strategy for Severe COVID-19 in Multiple Myeloma Patients Yan Nouet, Muskan Joshi, Viviana Cortiana, Gayathri Pramil, Alexandra van de Kieft, Chandler H. Park
4 [GO] 2024―Aug―26 MDS-242 Correlation Between Myelodysplastic Syndrome and COVID-19 Infection Rana G. Abdelfatah, Salma Abdelghany Shawkat, Menna Abdelghany Ali, Enaam Ali Al Mwafy, Nermine Moheb Mettias
5 [GO] 2024―Aug―26 AML-230 The Impact of COVID-19 on Acute Myeloid Leukemia (AML): A Propensity Matched Analysis Barath Prashanth Sivasubramanian, Diviya Bharathi Ravikumar, Abul Hasan Shadali Abdul Khader, Ibthisam Ismail Sharieff, Tenzin Tamdin, Raghavendra Tirupathi, Mamtha Balla
6 [GO] 2024―Aug―26 AML-045 Impact of COVID-19 on the Clinical Characteristics and Outcomes of Patients With Acute Leukemias: An Academic Center Experience Al Yaqadhan Al Kindi, Thuraya Al-Busaidi, Yahya Al-Kindi, Fatma Al-Bulushi, Mohamed Al-Hanini, Maryam Al-Bakri, Murtadha Al-Khabori
7 [GO] 2024―Aug―26 MM-593 Sociodemographic Trends in Multiple Myeloma-Related Mortality From 1999 to 2020 and Effect of the COVID-19 Pandemic Parisa Aijaz, Hira Shaikh, Amir Kamran
8 [GO] 2024―Aug―26 TCL-760 Hemophagocytic Lymphohistiocytosis in COVID-19: A Retrospective Analysis of Risks, Outcomes, and Health Care Burden in US Hospitals Dharmik Patel, Rushin Patel, Adit Dharia, Mrunal Patel, Darshil Patel, Zalak Patel, et al. (+4)
9 [GO] 2024―Aug―26 Sociodemographic Trends in Multiple Myeloma-Related Mortality From 1999 to 2020 and Effect of the COVID-19 Pandemic Parisa Aijaz, Hira Shaikh, Amir Kamran
10 [GO] 2024―Aug―26 MM-761 Multiple Myeloma Mortality Trends Before Pandemic, Stratified by Year Sex, and Race: 1999-2019 Muhammad Faisal Aslam, Muhammad Faisal Aslam
11 [GO] 2024―Aug―26 Multiple Myeloma Mortality Trends Before Pandemic, Stratified by Year, Sex, and Race: 1999-2019 Muhammad Faisal Aslam, Muhammad Hisham Khan Wazir
12 [GO] 2024―Aug―26 Exosomal Vesicles as a Promising Strategy for Severe COVID-19 in Multiple Myeloma Patients Yan Leyfman, Muskan Joshi, Viviana Cortiana, Gayathri Pramil, Alexandra van de Kieft, Chandler H. Park
13 [GO] 2024―Aug―26 Correlation Between Myelodysplastic Syndrome and COVID-19 Infection Rana G. Abdelfatah, Salma Abdelghany Shawkat, Menna Abdelghany Ali, Enaam Ali Al Mwafy, Nermine Moheb Mettias
14 [GO] 2024―Aug―26 The Impact of COVID-19 on Acute Myeloid Leukemia (AML): A Propensity Matched Analysis Barath Prashanth Sivasubramanian, Diviya Bharathi Ravikumar, Abul Hasan Shadali Abdul Khader, Ibthisam Ismail Sharieff, Tenzin Tamdin, Raghavendra Tirupathi, Mamtha Balla
15 [GO] 2024―Aug―26 Hemophagocytic Lymphohistiocytosis in COVID-19: A Retrospective Analysis of Risks, Outcomes, and Health Care Burden in US Hospitals Dharmik Patel, Rushin Patel, Adit Dharia, Mrunal Patel, Darshil Patel, Zalak Patel, et al. (+4)
16 [GO] 2024―Jan―21 Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy: A Prospective Cohort Study Alexandra Hillyer, Anthony Quint, Artin Ghassemian, Nicolette Joh-Carnella, Michael J. Knauer, Danny Dawd, et al. (+12)
17 [GO] 2023―Sep―26 P-469 Observational study of COVID-19 prophylactic antibody (tixagevimab/cilgavimab) administration for multiple myeloma patients Yoojin Lee, Jae-Cheol Jo
18 [GO] 2023―Sep―26 P-378 Longitudinal antibody and T-cell kinetics over four doses of COVID-19 vaccination and predictors of poor response in patients with multiple myeloma Gaurav Agarwal, Sally Moore, Ross Sadler, Sherin Varghese, Alison Turner, Lucia Chen, et al. (+17)
19 [GO] 2023―Sep―26 P-400 An immune atlas of the dysfunctional cellular and antibody response to COVID-19 vaccination in patients with multiple myeloma Esperanza Martin-Sanchez, Camila Guerrero, Luis-Esteban Tamariz-Amador, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, et al. (+15)
20 [GO] 2023―Sep―26 P-393 COVID-19 vaccine acceptance/hesitancy and influence on infection in patients with multiple myeloma: a national-wide multicenter survey in China Huiwen He, Ziping Li, Shuangjiao Liu, Wenming Chen, Wanling Sun, Baolai Hua, et al. (+2)
21 [GO] 2023―Sep―26 P-477 Pre-exposure prophylaxis for COVID-19 with tixagevimab/cilgavimab (evusheld) in patients with multiple myeloma in the omicron SARS-COV-2 era Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Vassiliki Spiliopoulou, Rodanthi-Eleni Syrigou, et al. (+7)
22 [GO] 2023―Sep―26 P-379 Variable humoral and cellular responses to SARS-CoV-2 bivalent booster vaccination in patients with multiple myeloma Adolfo Aleman, Morgan van Kesteren, Ariel Kogan-Zajdman, Bhaskar Upadhyaya, Lucia Chen, Annika Oostenink, et al. (+13)
23 [GO] 2023―Sep―26 P-398 Dynamic immune response in multiple myeloma patients infected with SARS-CoV-2 omicron BA.4/5 subvariant in China Ziping Li, Huiwen He, Haolong Li, Shuangjiao Liu, Fujing Zhang, Yongzhe Li, Junling Zhuang
24 [GO] 2023―Aug―31 ABCL-529 The Difference in Mortality, Seroconversion, and Duration of Hospitalization Between Patients With and Without Anti-CD20 Antibody Therapy Among Hematological Malignancies With Superadded COVID-19 Infection Charan Thej Reddy Vegivinti, Rahul Thakur, Jeevan Shivakumar, M Bakri Hammami, Mansi Mehta, Jaison Lawrence Alexander Santhi, et al. (+10)
25 [GO] 2023―Aug―31 POSTER: ABCL-529 The Difference in Mortality, Seroconversion, and Duration of Hospitalization Between Patients With and Without Anti-CD20 Antibody Therapy Among Hematological Malignancies With Superadded COVID-19 Infection Charan Thej Reddy Vegivinti, Rahul Thakur, Jeevan Shivakumar, M Bakri Hammami, Mansi Mehta, Jaison Lawrence Alexander Santhi, et al. (+10)
26 [GO] 2023―Aug―31 MM-126 The Invisible Damage of the COVID-19 Pandemic to Our Apheresia Unit and the National Economy Gülşah Akyol, Mustafa Baydar, Serpil Baysal, Muzaffer Keklik, Ali Ünal
27 [GO] 2023―Aug―31 CT-150 COVID-19 Vaccination-Associated Acquired Thrombotic Thrombocytopenic Purpura (TTP) Ruveyda Silay, Nigar Taghiyeva, Simge Erdem, Mustafa Nuri Yenerel
28 [GO] 2023―Aug―31 POSTER: CT-150 COVID-19 Vaccination-Associated Acquired Thrombotic Thrombocytopenic Purpura (TTP) Ruveyda Silay, Nigar Taghiyeva, Simge Erdem, Mustafa Nuri Yenerel
29 [GO] 2023―Aug―31 CML-084 COVID-19 - Trigger for Chronic Myeloid Leukemia Evolution? Viola Popov, Mihaela Andreescu
30 [GO] 2023―Aug―31 IBCL-057 Incidence and Features of SARS-CoV-2 Breakthrough Infection in the Hematological Conditions After Tixagevimab-Cilgavimab Prophylaxis Andrea Duminuco, Antonella Nardo, Alessandra Orofino, Giuliana Giunta, Concetta Conticello, Vittorio Del Fabro, et al. (+11)
31 [GO] 2023―Aug―31 POSTER: IBCL-057 Incidence and Features of SARS-CoV-2 Breakthrough Infection in the Hematological Conditions After Tixagevimab-Cilgavimab Prophylaxis Andrea Duminuco, Antonella Nardo, Alessandra Orofino, Giuliana Giunta, Concetta Conticello, Vittorio Del Fabro, et al. (+11)
32 [GO] 2023―Aug―31 IBCL-265 Compassionate Use of Plitidepsin in Patients With Non-Hodgkin Lymphoma (NHL) and SARS-CoV-2 Infection Alicia Ortiz Lopez, Elena Saiz Lou, Raquel Lloris Fernandez, Diego Lopez Mendoza, Raquel de la Oña, Monica Estevez, et al. (+4)
33 [GO] 2023―Aug―31 POSTER: IBCL-265 Compassionate Use of Plitidepsin in Patients With Non-Hodgkin Lymphoma (NHL) and SARS-CoV-2 Infection Alicia Ortiz Lopez, Elena Saiz Lou, Raquel Lloris Fernandez, Diego Lopez Mendoza, Raquel de la Oña, Monica Estevez, et al. (+4)
34 [GO] 2023―Aug―31 CML-425 Evaluation of Antibody Responses among Five Different SARS-Cov-2 Vaccines in Chronic Myeloid Leukemia (CML) Patients - A Real-World Study Ana Toreli, Marisol Miranda-Galvis, Marcelo Addas-Carvalho, Eliana Miranda, Leonardo Fechio, Adriana Duarte, et al. (+12)
35 [GO] 2023―Aug―31 POSTER: CML-425 Evaluation of Antibody Responses among Five Different SARS-Cov-2 Vaccines in Chronic Myeloid Leukemia (CML) Patients - A Real-World Study Ana Toreli, Marisol Miranda-Galvis, Marcelo Addas-Carvalho, Eliana Miranda, Leonardo Fechio, Adriana Duarte, et al. (+12)
36 [GO] 2023―Apr―28 Risk and Severity of COVID-19 Infection in Monoclonal Gammopathy of Undetermined Significance: A 3-Year Propensity Matched Cohort Study Omer S Ashruf, Zara Orozco, David C Kaelber
37 [GO] 2023―Apr―14 CLINICAL OUTCOMES IN PATIENTS WITH COVID-19 AND HEMATOLOGIC DISEASE Olga A. Aleshina, Kristina Zakurdaeva, Anastasia N. Vasileva, Sergey K. Dubov, Vitaly S. Dubov, Vladimir I. Vorobyev, et al. (+29)
38 [GO] 2023―Mar―07 Response to COVID-19 vaccination post CAR T therapy in patients with non-Hodgkin lymphoma and multiple myeloma Julia E. Wiedmeier-Nutor, Madiha Iqbal, Allison C. Rosenthal, Evandro D. Bezerra, Juan Esteban Garcia-Robledo, Radhika Bansal, et al. (+29)
39 [GO] 2023―Jan―18 Retrospective review of outcomes of Multiple Myeloma (MM) patients with COVID-19 infection (two-center study) Hamid Ehsan, Alec Britt, Peter M Voorhees, Barry Paul, Manisha Bhutani, Cindy Varga, et al. (+5)
40 [GO] 2022―Sep―21 Poster: TCL-458 Real-World Treatment Patterns in Patients With Sézary Syndrome in the United States and the Impact of Covid-19 Yang Zhao, Jackson Tang, Huanxue Zhou, Takeshi Takahashi, Takanobu Nomura, Eslie Dennis, Oleg Akilov
41 [GO] 2022―Sep―21 TCL-458 Real-World Treatment Patterns in Patients With Sézary Syndrome in the United States and the Impact of Covid-19 Yang Zhao, Jackson Tang, Huanxue Zhou, Takeshi Takahashi, Takanobu Nomura, Eslie Dennis, Oleg Akilov
42 [GO] 2022―Sep―21 CML-127 Results of a Vaccination Against COVID-19 by a Vector Based Vaccine Sputnik V in Patients With Chronic Myeloid Leukemia Ekaterina Chelysheva, Anna Petrova, Margarita Gurianova, Oleg Shukhov, Anastasia Bykova, Irina Nemchenko, et al. (+4)
43 [GO] 2022―Sep―21 Poster: CML-127 Results of a Vaccination Against COVID-19 by a Vector Based Vaccine Sputnik V in Patients With Chronic Myeloid Leukemia Ekaterina Chelysheva, Anna Petrova, Margarita Gurianova, Oleg Shukhov, Anastasia Bykova, Irina Nemchenko, et al. (+4)
44 [GO] 2022―Sep―21 AML-174 Dilemma of Treating Acute Myeloid Leukemia Patient After Kidney Transplant in the COVID-19 Era Shaimaa El-Ashwah, Esraa Jamal, Ahmed ELazab, May Denewer, Metwaly Ibrahim Mortada, Mayada A. Ghannam, et al. (+8)
45 [GO] 2022―Sep―21 ALL-206 Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country Mahmoud Hammad, Lobna Shalaby, Iman Sidhom, Nancy Sherief, Ibrahim Abdo, Sonia Soliman, et al. (+10)
46 [GO] 2022―Sep―21 Poster: ALL-206 Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country Mahmoud Hammad, Lobna Shalaby, Iman Sidhom, Nancy Sherief, Ibrahim Abdo, Sonia Soliman, et al. (+10)
47 [GO] 2022―Sep―21 TCL-456 Real-World Use of Mogamulizumab among Patients With Mycosis Fungoides and Sézary Syndrome Before and During COVID-19 in the United States Yang Zhao, Jackson Tang, Huanxue Zhou, Takeshi Takahashi, Takanobu Nomura, Eslie Dennis, Ahmad Halwani
48 [GO] 2022―Sep―21 Poster: TCL-456 Real-World Use of Mogamulizumab among Patients With Mycosis Fungoides and Sézary Syndrome Before and During COVID-19 in the United States Yang Zhao, Jackson Tang, Huanxue Zhou, Takeshi Takahashi, Takanobu Nomura, Eslie Dennis, Ahmad Halwani
49 [GO] 2022―Sep―21 CLL-033 Is COVID-19 Infection a Trigger for Progression of CLL? Viola Popov, Horia Bumbea, Mihaela Andreescu, Geanina Ofiteru, Felicia Mihai, Mihaela Popescu, et al. (+4)
50 [GO] 2022―Sep―21 Poster: CLL-033 Is COVID-19 Infection a Trigger for Progression of CLL? Viola Popov, Horia Bumbea, Mihaela Andreescu, Geanina Ofiteru, Felicia Mihai, Mihaela Popescu, et al. (+4)
51 [GO] 2022―Sep―21 ALL-083 ALLogeneic Hematopoietic Stem Cell Transplantation of a R/R T-ALL Patient Given Nelarabine, 3 Weeks Post Moderate COVID-19 Infection in the Local Setting Flaryll Uong
52 [GO] 2022―Sep―21 Poster: ALL-083 Allogeneic Hematopoietic Stem Cell Transplantation of a R/R T-ALL Patient Given Nelarabine, 3 Weeks Post Moderate COVID-19 Infection in the Local Setting Flaryll Uong
53 [GO] 2022―Sep―21 CT-128 Simple Prognostic Markers in Patients With Hematological Malignancies and COVID-19 Infection: Single-Center Experience Nahed Moawad Rakha, Noha Bassiouny, Dalia Abdel-Sattar, Nour Elhuda Hussien
54 [GO] 2022―Sep―21 Poster: CT-128 Simple Prognostic Markers in Patients With Hematological Malignancies and COVID-19 Infection: Single-Center Experience Nahed Moawad Rakha, Noha Bassiouny, Dalia Abdel-Sattar, Nour Elhuda Hussien
55 [GO] 2022―Sep―21 CLL-393 Outcomes of COVID-19 Infections in Patients With Hematological Malignancies in Republic of North Macedonia Milche Cvetanoski, Nevenka Ridova, Simona Stojanovska, Lazar Chadievski, Marija Popova Labachevska, Zlate Stojanoski, et al. (+11)
56 [GO] 2022―Sep―21 ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study Odil Giladi, Gianmarco Bagnato, Marianna Gentilini, Shai Shimony, Oren Pasvolsky, Tamar Berger, et al. (+8)
57 [GO] 2022―Sep―21 Poster: ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study Odil Giladi, Gianmarco Bagnato, Marianna Gentilini, Shai Shimony, Oren Pasvolsky, Tamar Berger, et al. (+8)
58 [GO] 2022―Sep―21 CLL-211 Humoral Immune Response Following COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin Lymphoma (NHL): Results From a Large, Single-Center Observational Study Frédérique St-Pierre, Peter Doukas, Jennifer Boyer, Mariana Nieves, Shuo Ma
59 [GO] 2022―Sep―21 Poster: CLL-211 Humoral Immune Response Following COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin Lymphoma (NHL): Results From a Large, Single-Center Observational Study Frédérique St-Pierre, Peter Doukas, Jennifer Boyer, Mariana Nieves, Shuo Ma
60 [GO] 2022―Sep―21 IBCL-054 The Effects of an mRNA COVID-19 Vaccine Booster on Immune Responses in Cancer-Bearing Veterans Arthur Frankel, Tazio Capozzola, Raiees Andrabi, Chul Ahn, Dennis Burton
61 [GO] 2022―Sep―21 CT-157 Another Rare Case of COVID-19 Vaccine Induced Acquired Hemophilia Asmaa M. Ismail
62 [GO] 2022―Sep―21 CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL Antonella Capasso, Elisa Albi, Luana Schiattone, Francesca Martini, Emanuela Sant'Antonio, Lydia Scarfò, et al. (+7)
63 [GO] 2022―Sep―21 Poster: CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL Antonella Capasso, Elisa Albi, Luana Schiattone, Francesca Martini, Emanuela Sant'Antonio, Lydia Scarfò, et al. (+7)
64 [GO] 2022―Sep―21 CLL-224 Coronavirus Disease Mortality and Outcome in Macedonian Patients With Chronic Lymphocytic Leukemia: Single-Center Experience Sanja Trajkova, Aleksandra Pivkova Veljanovska, Marija Popova Labacevska, Nevenka Ridova, Simona Stojanovska, Dushko Dukovski, Irina Panovska Stavridis
65 [GO] 2022―Sep―21 Poster: CLL-224 Coronavirus Disease Mortality and Outcome in Macedonian Patients With Chronic Lymphocytic Leukemia: Single-Center Experience Sanja Trajkova, Aleksandra Pivkova Veljanovska, Marija Popova Labacevska, Nevenka Ridova, Simona Stojanovska, Dushko Dukovski, Irina Panovska Stavridis
66 [GO] 2022―Sep―21 CML-384 Immunological Response to SARS-CoV-2 After Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - A Prospective Study Marisol Miranda Galvis, Danielle Bradshaw, Jaspreet Farmaha, Kimya Jones, Harmanpreet Singh, Ashutosh Vashisht, et al. (+3)
67 [GO] 2022―Sep―21 Poster: CML-384 Immunological Response to SARS-CoV-2 After Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - A Prospective Study Marisol Miranda Galvis, Danielle Bradshaw, Jaspreet Farmaha, Kimya Jones, Harmanpreet Singh, Ashutosh Vashisht, et al. (+3)
68 [GO] 2022―Sep―21 CLL-050 Induction of Neutralizing Antibodies in Chronic Lymphocytic Leukemia Patients After SARS-CoV-2 mRNA Vaccination: A Monocentric Experience Fabrizio Mavilia, Federico Pratesi, Claudia Baratè, Edoardo Benedetti, Valentina Guerri, Paola Sammuri, et al. (+2)
69 [GO] 2022―Sep―21 Poster: CLL-050 Induction of Neutralizing Antibodies in Chronic Lymphocytic Leukemia Patients After SARS-CoV-2 mRNA Vaccination: A Monocentric Experience Fabrizio Mavilia, Federico Pratesi, Claudia Baratè, Edoardo Benedetti, Valentina Guerri, Paola Sammuri, et al. (+2)
70 [GO] 2022―Sep―21 CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL Emily Bryer, Shira Paul, Jonathan Chen, Christopher Pleyer, Adrian Wiestner, Clare Sun
71 [GO] 2022―Sep―21 Poster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL Emily Bryer, Shira Paul, Jonathan Chen, Christopher Pleyer, Adrian Wiestner, Clare Sun
72 [GO] 2022―Sep―21 CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Andres Chang, Lilin Lai, Akil Akhtar, Susanne Linderman, Victor Orellana-Noia, Manpreet Saini, et al. (+15)
73 [GO] 2022―Sep―21 Poster: CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Andres Chang, Lilin Lai, Akil Akhtar, Susanne Linderman, Victor Orellana-Noia, Manpreet Saini, et al. (+15)
74 [GO] 2022―Aug―25 P-161: Oral antivirals ritonavir-nirmatrelvir and molnupiravir are highly effective in patients with multiple myeloma and COVID-19; a singlecenter, prospective study Vassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, et al. (+6)
75 [GO] 2022―Aug―25 P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents Ioannis Ntanasis-Stathopoulos, Vangelis Karalis, Maria Gavriatopoulou, Aimilia D Sklirou, Panagiotis Malandrakis, Magdalini Migkou, et al. (+9)
76 [GO] 2022―Mar―28 COVID-19 mRNA vaccine in patients with lymphoid malignancy or anti-CD20 antibody therapy: a systematic review and meta-analysis Yusuke Ito, Akira Honda, Mineo Kurokawa
77 [GO] 2021―Dec―26 Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19 Michael R. Cook, Kaitlyn Dykes, Katherine White, Sameer Desale, Rajeev Agrawal, Stephen Fernandez, et al. (+3)
78 [GO] 2021―Nov―11 COVID-19 vaccine responses in patients with plasma cell dyscrasias after complete vaccination Mansi R. Shah, Alissa Gabel, Stephanie Beers, Gratian Salaru, Yong Lin, Dennis L. Cooper
79 [GO] 2021―Nov―10 OAB-046: COVID-19 infection in multiple myeloma patients - retrospective analysis of 371 Czech patients Jakub Radocha, Ivan Špička, Luděk Pour, Tomas Jelinek, Alexandra Jungova, Jiri Minarik, et al. (+11)
80 [GO] 2021―Nov―10 OAB-045: COVID-19 vaccine responsiveness in patients with Multiple Myeloma and Waldenström Macroglobulinemia Andrew Branagan, Matthew Lei, Andrew J. Yee, Elizabeth O’Donnell, Jorge J. Castillo, Noopur Raje, et al. (+19)
81 [GO] 2021―Nov―10 OAB-047: Plasma cell disorder patients are left vulnerable after one dose of the BNT162b2 mRNA or the ChAdOx-nCOV-19 COVID-19 vaccines Wei Yee Chan, Lara Howells, William Wilson, Emilie Sanchez, Louise Ainley, Selina Chavda, et al. (+16)
82 [GO] 2021―Nov―10 OAB-048: Suboptimal humoral immune response to SARS-CoV-2 mRNA vaccination in myeloma patients is associated with anti-CD38 mAb and BCMA-targeted treatment Oliver Van Oekelen, Sarita Agte, Charles Gleason, Komal Srivastava, Katherine Beach, Adolfo Aleman, et al. (+11)
83 [GO] 2021―Nov―10 P-147: COVID-19, impact of vaccination in myeloma patients Ellen Hoornaert, François Dachy, Amandine Hansenne, Eugénie Lagneaux, Damien Gruson, Sarah Bailly, Marie Vekemans
84 [GO] 2021―Nov―10 P-130: The impact of COVID-19 on the treatment regimens of myeloma and AL amyloidosis patients Katie Joyner, Jayne Galinsky, Solène Clavreul
85 [GO] 2021―Nov―10 P-143: Breakthrough - a designated pharmacist in the hemato-oncology department improves both quality and sequence of drug treatment and reduces ADR in Multiple Myeloma patients during Covid-19 pandemic Areen Alabbasi, Shai Cohen, Manfred Green, Shuli Brammli, Meir Preis, Rasmieh Khalaily
86 [GO] 2021―Nov―10 NS-64: Lessons learned: patient management and outcomes of Multiple Myeloma patients during the COVID-19 pandemic in New York City Donna Catamero, Oliver Van Oekelen, Tarek Mouhieddine, Bo Wang, Megan Metzger, Joshua Richter, et al. (+2)
87 [GO] 2021―Nov―10 NP-114: Lesson Learned: Management of patients with Multiple Myeloma (MM) and their response to two doses of COVID-19 RNA vaccine Daniel Verina, Oliver Van Oekelen, Charles Gleason, Sarita Agte, Komal Srivastava, Katherine Beach, et al. (+9)
88 [GO] 2021―Nov―10 P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, et al. (+10)
89 [GO] 2021―Nov―10 P-144: Response to SARS-CoV-2 vaccination in patients with Multiple Myeloma using a 12-week spaced dosing strategy Sarah Bird, Aikaterini Panopoulou, Robyn Shea, Micky Tsui, Radovan Saso, Amit Sud, et al. (+9)
90 [GO] 2021―Nov―10 P-149: Immunogenicity of SARS-CoV-2 vaccine in patients with multiple myeloma Florent Malard, Béatrice Gaugier, Joel Gozlan, Lucie Bouquet, Djeneba Fofana, Zoe Van De Wyngaert, et al. (+4)
91 [GO] 2021―Nov―10 NS-63: Adapting and improving a Myeloma Support group during the pandemic Emma Dowling, Margareta Sowton, Nuno Correia, Darren Simpson
92 [GO] 2021―Aug―30 AML-355: Incidence and Severity of COVID-19 among Inpatients with Hematologic Malignancies Natalia Wozniaki, Marcelo Pitombeira Lacerda, JoãoPedro Ribeiro Baptista, Helio Vida Cassi, Gabriela Duarte Neves, Ivan Schneider Boettcher, et al. (+4)
93 [GO] 2021―Aug―30 Poster: AML-355: Incidence and Severity of COVID-19 among Inpatients with Hematologic Malignancies Natalia Wozniaki, Marcelo Pitombeira Lacerda, JoãoPedro Ribeiro Baptista, Helio Vida Cassi, Gabriela Duarte Neves, Ivan Schneider Boettcher, et al. (+4)
94 [GO] 2021―Aug―30 MM-219: Outcome of COVID-19 Among Patients with Multiple Myeloma at the Armenian Hematology Center Lusine Sahakyan, Gayane Grigoryan, Yervand Hakobyan
95 [GO] 2021―Aug―30 Poster: MM-219: Outcome of COVID-19 Among Patients with Multiple Myeloma at the Armenian Hematology Center Lusine Sahakyan, Gayane Grigoryan, Yervand Hakobyan
96 [GO] 2021―Aug―30 ABCL-441: Demographic and Quality of Life Model Applications to High-Grade Non-Hodgkin Lymphoma Patients in the COVID-19 Era Ayman Youssef, Dalia Nafea, Nahla Hamed, Israa Okap, Amany Abdelbary, Nermeen Afifi, et al. (+4)
97 [GO] 2021―Aug―30 Poster: ABCL-441: Demographic and Quality of Life Model Applications to High-Grade Non-Hodgkin Lymphoma Patients in the COVID-19 Era Ayman Youssef, Dalia Nafea, Nahla Hamed, Israa Okap, Amany Abdelbary, Nermeen Afifi, et al. (+4)
98 [GO] 2021―Aug―30 AML-168: The Assessment of COVID-19 Evolution in Patients with Oncological Diseases Admitted in an Intensive Care Unit of One Romanian Center Viola Maria Popov, Lelia Iliescu, Catalina Pirvu, Andra Grigorie, Oana Constantin, Ana Rus, et al. (+4)
99 [GO] 2021―Aug―30 Poster: AML-168: The Assessment of COVID-19 Evolution in Patients with Oncological Diseases Admitted in an Intensive Care Unit of One Romanian Center Viola Maria Popov, Lelia Iliescu, Catalina Pirvu, Andra Grigorie, Oana Constantin, Ana Rus, et al. (+4)
100 [GO] 2021―Aug―30 ALL-098: COVID-19 in Children with Cancer: What We Learned from the First Wave Fatma Ebeid, Amira Adly, Sara Makkeyah, Salwa Mostafa, Iman Ragab
101 [GO] 2021―Aug―30 Poster: ALL-098: COVID-19 in Children with Cancer: What We Learned from the First Wave Fatma Ebeid, Amira Adly, Sara Makkeyah, Salwa Mostafa, Iman Ragab
102 [GO] 2021―Aug―30 MPN-433: Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: A Single-Institution, Observational Study Sami Dwabe, Lakshmi Savitala-Damerla, Abdullah Ladha, Eric Tam, Preet Chaudhary, George Yaghmour
103 [GO] 2021―Aug―30 Poster: MPN-433: Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: A Single-Institution, Observational Study Sami Dwabe, Lakshmi Savitala-Damerla, Abdullah Ladha, Eric Tam, Preet Chaudhary, George Yaghmour
104 [GO] 2021―Aug―30 AML-075: Converting In-Person Research Procedures to a Virtual Platform During the COVID-19 Pandemic in Newly Diagnosed Acute Myeloid Leukemia Patients Sara Tinsley, Cecile Lengacher
105 [GO] 2021―Aug―30 Poster: AML-075: Converting In-Person Research Procedures to a Virtual Platform During the COVID-19 Pandemic in Newly Diagnosed Acute Myeloid Leukemia Patients Sara Tinsley, Cecile Lengacher
106 [GO] 2021―Aug―30 ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study Annuja Anandaradje, Luxitaa Goenka, Biswajit Dubashi, Smita Kayal, Dhanapati Halanaik, Debdatta Basu, Prasanth Ganesan
107 [GO] 2021―Aug―30 Poster: ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study Annuja Anandaradje, Luxitaa Goenka, Biswajit Dubashi, Smita Kayal, Dhanapati Halanaik, Debdatta Basu, Prasanth Ganesan
108 [GO] 2021―Aug―30 AML-145: Outcomes of Induction Therapy in Patients with Acute Myeloid Leukemia During Covid-19 Pandemic: A Retrospective Study from a Tertiary Care Cancer Centre Asif Iqbal, Nithin Daniel, Raghavendra Reddy, Munlima Hazarika
109 [GO] 2021―Aug―30 Poster: AML-145: Outcomes of Induction Therapy in Patients with Acute Myeloid Leukemia During Covid-19 Pandemic: A Retrospective Study from a Tertiary Care Cancer Centre Asif Iqbal, Nithin Daniel, Raghavendra Reddy, Munlima Hazarika
110 [GO] 2021―Aug―30 AML-192: Enhancer of Zeste Homolog 2 (EZH2) in COVID-19-Positive Acute Myeloid Leukemia Nahla Hamed, Omar Gallab, Reham Abdelhalim, Mohamed Rezk
111 [GO] 2021―Aug―30 ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry Olga Gavrilina, Kristina Zakurdaeva, Anastasia Vasileva, Vladimir Vorobyev, Lev Butaev, Vitaly Dubov, et al. (+18)
112 [GO] 2021―Aug―30 Poster: ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry Olga Gavrilina, Kristina Zakurdaeva, Anastasia Vasileva, Vladimir Vorobyev, Lev Butaev, Vitaly Dubov, et al. (+18)
113 [GO] 2021―Aug―30 CT-107: Coronavirus Disease in Bone Marrow Transplant (BMT) Recipients at Edgardo Rebagliati Martins Hospital (HNERM) Lima, Peru Susy Bazan, Ruben Rodriguez, Vladimir Espinioza, Alfredo Wong, Melissa Morales-Coloma, Juan Navarro, Lourdes Aranda
114 [GO] 2021―Aug―30 Poster: CT-107: Coronavirus Disease in Bone Marrow Transplant (BMT) Recipients at Edgardo Rebagliati Martins Hospital (HNERM) Lima-Peru Susy Bazan, Ruben Rodriguez, Vladimir Espinioza, Alfredo Wong, Melissa Morales-Coloma, Juan Navarro, Lourdes Aranda
115 [GO] 2021―Aug―30 CML-005: Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with a Donor and Recipient with SARS-CoV-2 Infection Gadallah Ali, Majed Altareb, Naeem Chaudhri
116 [GO] 2021―Aug―30 ABCL-013: Factors Associated with SARS-CoV-2 Infection and Outcome in Patients with Solid Tumors or Hematological Malignancies: A Single-Center Study Anouk Goudsmit, Edouard Cubilier, Anne-Pascale Meert, Philippe Aftimos, Konstantinos Stathopoulos, Chloé Spilleboudt, Angela Loizidou
117 [GO] 2021―Aug―30 Poster: ABCL-013: Factors Associated with SARS-CoV-2 Infection and Outcome in Patients with Solid Tumors or Hematological Malignancies: A Single-Center Study Anouk Goudsmit, Edouard Cubilier, Anne-Pascale Meert, Philippe Aftimos, Konstantinos Stathopoulos, Chloé Spilleboudt, Angela Loizidou
118 [GO] 2021―Jul―26 Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country Mahmoud Hammad, Lobna Shalaby, Iman Sidhom, Nancy Sherief, Ibrahim Abdo, Sonia Soliman, et al. (+10)
119 [GO] 2021―Jul―18 Resolution of one-year persisting COVID-19 pneumonia and development of immune thrombocytopenia in a follicular lymphoma patient with preceding rituximab maintenance therapy: a follow-up report and literature review of cases with prolonged infections Hajime Yasuda, Yosuke Mori, Asako Chiba, Jie Bai, Goh Murayama, Yasushi Matsushita, et al. (+2)
120 [GO] 2021―Jul―18 Frequency, clinical characteristics and outcome of adults with acute lymphoblastic leukemia and COVID 19 infection in the first vs. second pandemic wave in Spain Josep-Maria Ribera, Mireia Morgades, Rosa Coll, Pere Barba, Jose-Luis López-Lorenzo, Pau Montesinos, et al. (+24)
121 [GO] 2021―May―31 COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic Martin Čerňan, Tomáš Szotkowski, Aleš Obr, Vojtěch Látal, Antonín Hluší, Petra Krhovská, et al. (+6)
122 [GO] 2021―May―21 DRAMATIC RESPONSE TO CONVALESCENT HYPERIMMUNE PLASMA IN ASSOCIATION WITH AN EXTENDED COURSE OF REMDESIVIR IN FOUR B-CELL DEPLETED NON HODGKIN LYMPHOMA PATIENTS WITH SARS-COV-2 PNEUMONIA AFTER RITUXIMAB THERAPY Anna Furlan, Gabriella Forner, Ludovica Cipriani, Elisa Vian, Roberto Rigoli, Filippo Gherlinzoni, Piergiorgio Scotton
123 [GO] 2021―Feb―27 Delayed COVID-19 Respiratory Failure in Lymphoma Patients on Rituximab-based Chemoimmunotherapy Marc S Hoffmann, Siddhartha Ganguly
124 [GO] 2021―Jan―14 Severe and irreversible pancytopenia associated with SARS-CoV-2 bone marrow infection in a Waldenstrom’s Macroglobulinemia patient Mélanie Velier, Stéphane Priet, Romain Appay, Thérèse Atieh, Hubert Lepidi, Gilles Kaplanski, et al. (+12)
125 [GO] 2021―Jan―14 Treatment of Acute Leukemia during COVID-19: Focused review of evidence Suvir Singh, Jagdeep Singh, Davinder Paul, Kunal Jain
126 [GO] 2020―Dec―10 ABCL-093: The Single-Center Analysis of Survival and Mortality in Patients with Hematological Diseases and COVID-19 in Russia Olga Gavrilina, Tatyana Gaponova, Vera Troitskaya, Elena Parovichnikova, Gennadiy Galstyan, Karen Danishyan, et al. (+15)
127 [GO] 2020―Dec―10 AML-335: Treating Hematologic Oncology Patients in the Developing World During the COVID-19 Pandemic Liana Hambardzumyan, Maria Badikyan, Hayk Grigoryan, Artashes Tadevosyan, Tatevik Grigoryan, Nare Martirosyan, et al. (+6)
128 [GO] 2020―Dec―10 CT-365: The Evaluation of Haematological and Biochemistry Parameters in COVID-19 Patients as a Predictive Factor for Unfavourable Evolution Viola Popov, Lelia Iliescu, Marius loan Balea, Mihaela Andreescu, Mihaela Popescu, Oana Patrinoiu, et al. (+16)
129 [GO] 2020―Dec―10 MM-239: A Tertiary Center Experience of Multiple Myeloma Patients with COVID-19: Lessons Learned and the Path Forward Bo Wang, Oliver Van Oekelen, Tarek Mouhieddine, Sundar Jagannath, Samir Parekh, Deepu Madduri
130 [GO] 2020―Dec―10 CLL-370: The Prolonged Positivity of SARS-CoV-2 RNA in Chronic Lymphocytic Leukemia Patients Viola Popov, Mihaela Andreescu, Oana Patrinoiu, Mihaela Popescu, Claudia Despan, Meilin Omer, et al. (+5)
131 [GO] 2020―Dec―10 CT-152: Application of Web-Scraping Techniques for Autonomous Massive Retrieval of Hematologic Patients' Information During SARS-CoV2 Pandemic Raul Azibeiro Melchor, Marta Fonseca, Beatriz Rey, Alberto Hernandez, Borja Puertas, Sandra Gomez, et al. (+4)
132 [GO] 2020―Dec―10 MPN-182: Transfusion in Hematology Patients During the COVID19 Pandemic: A Systematic Review Marcel Massoud, Christelle El Riachy
133 [GO] 2020―Aug―22 Persistent covid-19 pneumonia and failure to develop anti-SARS-CoV-2 antibodies during rituximab maintenance therapy for follicular lymphoma Hajime Yasuda, Yutaka Tsukune, Naoki Watanabe, Kazuya Sugimoto, Ayana Uchimura, Misa Tateyama, et al. (+3)
134 [GO] 2020―Jun―25 Successful use of COVID-19 convalescent plasma in a patient recently treated for follicular lymphoma Zachary Wright, Adrian Bersabe, Rina Eden, Andrew Cap
135 [GO] 2020―Jun―25 Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant patient on Ruxolitinib Francine M. Foss, Ami Rubinowitz, Marie L. Landry, Iris Isufi, Lohith Gowda, Stuart Seropian, et al. (+2)
 [1] 

135 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.018 sec